Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Liabilities ₹405 Cr₹378 Cr₹308 Cr₹184 Cr₹181 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹405 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹405 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr
Mar2016₹181 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2024 ₹405 Cr
7.10
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr
1.81
Mar2016 ₹181 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,948.6 Cr 5.4% -5.9% 29.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,661.0 Cr -1.8% 2.7% 49.1% Stock Analytics
DIVIS LABORATORIES ₹160,496.0 Cr -0.2% -3.4% 57% Stock Analytics
CIPLA ₹121,970.0 Cr -0.7% 0.6% 22.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,877.0 Cr -1.8% 11.3% 18% Stock Analytics
ZYDUS LIFESCIENCES ₹98,163.2 Cr 1.9% 0.5% 41.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5.4%

-5.9%

29.5%

SENSEX

0.7%

-2%

9.7%


You may also like the below Video Courses